Ryszard Smolarczyk

Gliwice Branch, Wybrzeże Armii Krajowej Street 15
Gliwice, SL 44102, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

TLR7 Agonist Imiquimod Improves the Therapeutic Antitumor Effect of High-Dose-Rate Brachytherapy.

TLR7 Agonist Imiquimod Improves the Therapeutic Antitumor Effect of High-Dose-Rate Brachytherapy.

Journal: Cancers
Published: February 02, 2026

Minimizing systemic toxicity of doxorubicin via targeted delivery of hypoxia-sensitive polymersomes.

Minimizing systemic toxicity of doxorubicin via targeted delivery of hypoxia-sensitive polymersomes.

Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: October 29, 2025

Targeting STING Signalling Polarizes Tumor-Associated Neutrophils to Boost Anticancer and Abscopal Antimetastatic Functions.

Targeting STING Signalling Polarizes Tumor-Associated Neutrophils to Boost Anticancer and Abscopal Antimetastatic Functions.

Journal: ImmunoTargets and therapy
Published: October 24, 2025

Tailoring the Release of Paclitaxel from Electrospun Nonwovens.

Tailoring the Release of Paclitaxel from Electrospun Nonwovens.

Journal: International journal of molecular sciences
Published: October 24, 2025

Characteristics of NK cells activation following IL-12, IL-15, IL-18 cytokines stimulation for preclinical purposes.

Characteristics of NK cells activation following IL-12, IL-15, IL-18 cytokines stimulation for preclinical purposes.

Journal: Scientific reports
Published: October 21, 2025

Comparison of Micelles Single- and Dual-Targeted with Folic Acid and Biotin as the Delivery System of Docetaxel─The Influence of the Type and Amount of the Ligand on Morphology, Physicochemical Properties, and Cytotoxicity.

Comparison of Micelles Single- and Dual-Targeted with Folic Acid and Biotin as the Delivery System of Docetaxel─The Influence of the Type and Amount of the Ligand on Morphology, Physicochemical Properties, and Cytotoxicity.

Journal: Molecular pharmaceutics
Published: June 26, 2025

Correction: Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist.

Correction: Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist.

Journal: Cancer immunology, immunotherapy : CII
Published: May 27, 2025

Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes Statuses.

Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes Statuses.

Journal: Cancers
Published: November 07, 2024

Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies.

Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies.

Journal: Clinical and experimental medicine
Published: June 17, 2024

Combination of STING agonist with anti-vascular RGD-(KLAKLAK)2 peptide as a novel anti-tumor therapy.

Combination of STING agonist with anti-vascular RGD-(KLAKLAK)2 peptide as a novel anti-tumor therapy.

Journal: Cancer immunology, immunotherapy : CII
Published: April 05, 2024

Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context.

Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context.

Journal: Frontiers in oncology
Published: June 28, 2023

The Effect of Radiotherapy on Cell Survival and Inflammatory Cytokine and Chemokine Secretion in a Co-Culture Model of Head and Neck Squamous Cell Carcinoma and Normal Cells.

The Effect of Radiotherapy on Cell Survival and Inflammatory Cytokine and Chemokine Secretion in a Co-Culture Model of Head and Neck Squamous Cell Carcinoma and Normal Cells.

Journal: Biomedicines
Published: May 08, 2023
Showing 1-12 of 49

Last Updated: 09/26/2026